Breaking News Instant updates and real-time market news.

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

, AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

05:16
11/22/17
11/22
05:16
11/22/17
05:16

Axalta Coating confirms takeover talks with Nippon Paint

Axalta Coating Systems (AXTA) issued the following statement this morning: "Axalta today confirmed that it is engaged in discussions with Nippon Paint regarding a potential acquisition of Axalta. Axalta will pursue such a transaction only if its Board of Directors determines that it is in the best interest of Axalta to do so. There can be no assurances that a definitive agreement between the parties will be reached or on what terms." AkzoNobel (AKZOY) last night confirmed the company is no longer in talks to acquire Axalta.

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

AXTA Axalta Coating
$33.87

0.33 (0.98%)

11/22/17
SBSH
11/22/17
NO CHANGE
Target $34
SBSH
Neutral
Axalta remains potential acquisition target, says Citi
Citi analyst P.J. Juvekar expects "significant downward pressure" today in shares of Axalta Coating (AXTA) after AkzoNobel (AKZOY) confirmed that it has walked away from merger talks. When the initial news hit, Axalta shares jumped 17%, or nearly $5 per share, and since then are up another 2%, Juvekar tells investors in a research note. His bear case scenario for the shares if the deal did not happen is $28, or 10.8 times his 2018 EBITDA estimate. The analyst, however, thinks Axalta remains a potential acquisition target given the ongoing consolidation of the paints industry. He still thinks the involvement of Berkshire Hathaway (BRK.A, BRK.B) 10% owner, "is a wildcard." Nonetheless, Juvekar remains concerned about the company's near-term fundamentals and keeps a Neutral rating on Axalta with a $34 price target.
10/31/17
VERT
10/31/17
UPGRADE
Target $37
VERT
Buy
Axalta Coating upgraded to Buy from Hold at Vertical Research
Vertical Research analysts led by Kevin McCarthy upgrade Axalta Coating (AXTA) to Buy with a $37 price target citing news that AkzoNobel (AKZOY) may acquire the company. The analyst is not surprised by this potential combination and believes it can create substantial value for Axalta shareholders, particularly if Axalta's management were lead the combined company with a free hand to extract synergies. If a deal is struck, "Akzalta" would become the second-largest coatings company in the world, the analyst wrote.
10/30/17
DBAB
10/30/17
NO CHANGE
Target $32
DBAB
Buy
Axalta shares could be worth $45 in merger deal, says Deutsche Bank
Deutsche Bank analyst David Begleiter estimates Axalta Coating (AXTA) shares would be worth $45 in a merger of equals deal with AkzoNobel (AKZOY). The analyst believes a merger of equals makes sense, saying it would allow Axalta shareholders to share in the upside from costs savings and sales synergies at the new entity as well as operational improvement at Akzo. If Axalta were to be acquired by Akzo or someone else, its board would likely seek a valuation similar to what Sherwin-Williams (SHW) paid for Valspar, or around $41 per share, Begleiter tells investors in a research note titled "Merger Value Could be in the $40s." The analyst keeps a Hold rating on Axalta with a standalone price target of $32.
10/30/17
SBSH
10/30/17
UPGRADE
Target $34
SBSH
Neutral
Axalta Coating upgraded to Neutral from Sell at Citi
Citi analyst P.J. Juvekar upgraded Axalta Coating (AXTA) to Neutral citing news that AkzoNobel (AKZOY) may acquire the company. The analyst believes Axalta management would be willing sellers at the right price and that a potential buyout will support the stock. He upped his price target for Axalta shares to $34 from $25. An acquisition offer price in the high $30 per share range would be sufficient to get Axalta to the negotiating table, Juvekar tells investors in a research note.
AKZOY AkzoNobel
$30.57

0.085 (0.28%)

10/30/17
RBCM
10/30/17
NO CHANGE
Target $37
RBCM
Outperform
Axalta Coating price target raised to $37 from $32 at RBC Capital
RBC Capital analyst Arun Viswanathan raised his price target on Axalta Coating (AXTA) to $37 and kept his Outperform rating after Q3 results. While the company missed its EBITDA target, the analyst notes that double-digit growth in 2018 should be "very achievable" as distributor refinish destocking issues are now in the past. Viswanathan adds that his higher valuation forecast is also based on recent talks about a potential tie-up with AkzoNobel (AKZOY).

TODAY'S FREE FLY STORIES

MCD

McDonald's

$173.34

-0.21 (-0.12%)

, QSR

Restaurant Brands

$61.42

0.09 (0.15%)

15:32
12/14/17
12/14
15:32
12/14/17
15:32
Hot Stocks
Jim Chanos says not short McDonald's, but is short other fast food stocks »

Chanos, in making…

MCD

McDonald's

$173.34

-0.21 (-0.12%)

QSR

Restaurant Brands

$61.42

0.09 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$10.30

-0.66 (-6.02%)

15:30
12/14/17
12/14
15:30
12/14/17
15:30
Options
Express calls active as shares see relative weakness »

Express calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

, DIS

Disney

$111.17

3.555 (3.30%)

15:29
12/14/17
12/14
15:29
12/14/17
15:29
Recommendations
21st Century Fox, Disney analyst commentary  »

21st Century Fox should…

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

DIS

Disney

$111.17

3.555 (3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

TSLA

Tesla

$339.03

-2 (-0.59%)

15:28
12/14/17
12/14
15:28
12/14/17
15:28
Hot Stocks
Tesla 'already behind' on vehicle autonomy, Chanos says »

Jim Chanos of Kynikos…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

TSLA

Tesla

$339.03

-2 (-0.59%)

15:27
12/14/17
12/14
15:27
12/14/17
15:27
Hot Stocks
Chanos says Tesla CEO Musk 'has broad interpretation of truth' »

Jim Chanos, who is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

BTC

Bitcoin

, BITCOIN

Bitcoin

15:19
12/14/17
12/14
15:19
12/14/17
15:19
General news
Chanos says 'not short' bitcoin but 'speculation' in it indicative of market »

Jim Chanos of Kynikos…

BTC

Bitcoin

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$176.83

4.29 (2.49%)

15:19
12/14/17
12/14
15:19
12/14/17
15:19
Options
Adobe options imply 6.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

EADSY

Airbus

$26.16

0.62 (2.43%)

15:17
12/14/17
12/14
15:17
12/14/17
15:17
Periodicals
Breaking Periodicals news story on Airbus »

Airbus CEO intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:17
12/14/17
12/14
15:17
12/14/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.11

-0.75 (-3.14%)

, ESRX

Express Scripts

$68.57

0.01 (0.01%)

15:16
12/14/17
12/14
15:16
12/14/17
15:16
Periodicals
Chanos says tax bill will affect healthcare more than people think »

Chanos mentioned…

MNK

Mallinckrodt

$23.11

-0.75 (-3.14%)

ESRX

Express Scripts

$68.57

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

$NYE

NYSE Market Internals

15:16
12/14/17
12/14
15:16
12/14/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$266.05

-0.705 (-0.26%)

15:12
12/14/17
12/14
15:12
12/14/17
15:12
Periodicals
Speaker Ryan says not leaving Congress anytime soon, CBS News reports »

Following a media report…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$266.05

-0.705 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$2.93

-0.095 (-3.15%)

15:10
12/14/17
12/14
15:10
12/14/17
15:10
Options
Bulls and bears in JC Penney Thursday »

Bulls and bears in JC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$38.58

-0.93 (-2.35%)

, CMCSK

Comcast

15:06
12/14/17
12/14
15:06
12/14/17
15:06
Periodicals
Comcast offered more for Fox assets, but Fox preffered Disney deal, CNBC says »

Sources tell CNBC's…

CMCSA

Comcast

$38.58

-0.93 (-2.35%)

CMCSK

Comcast

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

FOX

21st Century Fox

$32.34

-1.26 (-3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

COST

Costco

$188.28

-0.02 (-0.01%)

15:04
12/14/17
12/14
15:04
12/14/17
15:04
Options
Costco options imply 5.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

VRX

Valeant

$19.22

-2.83 (-12.83%)

15:03
12/14/17
12/14
15:03
12/14/17
15:03
Technical Analysis
Technical View: Valeant near session lows, levels to watch »

The shares are bouncing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 27

    Dec

  • 18

    Jun

CI

Cigna

$204.17

-3.75 (-1.80%)

15:02
12/14/17
12/14
15:02
12/14/17
15:02
Hot Stocks
Cigna announces acquisition of digital health plan platform Brighter »

Cigna announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
12/14/17
12/14
15:00
12/14/17
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

ORCL

Oracle

$50.25

0.195 (0.39%)

14:49
12/14/17
12/14
14:49
12/14/17
14:49
Options
Oracle options imply 7.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DIS

Disney

$111.04

3.43 (3.19%)

, FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

14:44
12/14/17
12/14
14:44
12/14/17
14:44
Recommendations
Disney, 21st Century Fox analyst commentary  »

RBC Capital sees Disney,…

DIS

Disney

$111.04

3.43 (3.19%)

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

PGR

Progressive

$55.20

-0.66 (-1.18%)

14:40
12/14/17
12/14
14:40
12/14/17
14:40
Options
Notable put buying in Progressive »

Notable put buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRX

Valeant

$19.42

-2.6299 (-11.93%)

14:38
12/14/17
12/14
14:38
12/14/17
14:38
Hot Stocks
Valeant slips after JPMorgan says sell on stretched valuation, high expectations »

Shares of Valeant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 27

    Dec

  • 18

    Jun

LNCE

Snyder's-Lance

$39.41

0.16 (0.41%)

14:35
12/14/17
12/14
14:35
12/14/17
14:35
Hot Stocks
Breaking Hot Stocks news story on Snyder's-Lance »

Snyder's & Lance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ILG

ILG

$28.90

-0.12 (-0.41%)

14:35
12/14/17
12/14
14:35
12/14/17
14:35
Options
ILG Inc put volume heavy and directionally bearish »

Bearish flow noted in ILG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNCE

Snyder's-Lance

$39.41

0.16 (0.41%)

, CPB

Campbell Soup

$48.76

-0.43 (-0.87%)

14:33
12/14/17
12/14
14:33
12/14/17
14:33
Periodicals
Snyder's-Lance weighing sale after approach from Campbell Soup, CNBC says »

Snyder's-Lance…

LNCE

Snyder's-Lance

$39.41

0.16 (0.41%)

CPB

Campbell Soup

$48.76

-0.43 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.